Özlem Fentoğlu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Özlem Fentoğlu has a total of 65 co-authors. Here are the top co-authors by number of shared publications:
Hikmet Orhan
Faculty of Medicine, Department of Biostatistics, Isparta, Turkey
7 shared publications- Burak Doğan
Hatay Mustafa Kemal University
4 shared publications - Esra Sinem Kemer Doğan
Department of Periodontology, Faculty of Dentistry, Hatay Mustafa Kemal University, Hatay, Turkey
4 shared publications F. Yeşim Kırzıoğlu
Department of Periodontology, Faculty of Dentistry, University of Süleyman Demirel, Isparta, Turkey
4 shared publications- Fatma Yeşim Kırzıoğlu
Süleyman Demirel Üniversitesi
4 shared publications Atalay Doğru
Department of Internal Medicine, Division of Rheumatology, University of Süleyman Demirel, Isparta, Turkey
2 shared publications
Latest Publications
- Open Access
- 22 April 2024
- Published by SDU Journal of Health Sciences in Süleyman Demirel Üniversitesi Sağlık Bilimleri Dergisi
- Vol. 15 (1) , 142-164
Osteoporoz ve Periodontal Hastalıklar Arasındaki İlişki Üzerine Derleme
Periodontitis ve osteoporoz, yaşlanan nüfus için önemli halk sağlığı sorunları oluşturan yaygın inflamasyonla ilişkili durumlardır. Periodontal hastalıklar, ağırlıklı olarak dento-gingival dokulardaki disbiyozis ve inflamatuvar nitelikli bir dizi bozukluktan oluşur. Osteoporoz, artan kırık riski ile birlikte kemik mineral yoğunluğu (KMY)’ nun ve yapısının bozulması ile karakterize, yaşa bağlı bir kemik hastalığıdır. Bu derlemede, osteoporoz ve periodontitis arasındaki ilişki hakkında bir güncelleme sağlamak için son 25 yıldaki literatür değerlendirilip, bunların mekanistik bağlantılarının, ortak risk faktörlerinin ve terapötik etkilerinin tartışılması amaçlanmaktadır. Sistemik ve alveolar kemik kaybı (AKK) arasındaki ilişkiyi inceleyen klinik çalışmalarda, 1996-2020 yılları arasındaki 10 araştırma, KMY ile AKK arasında ters bir korelasyon olduğunu ortaya koymuştur. Alveolar kemik kaybının radyografik olarak değerlendirilmesi önemli bir kriter olsa da, klinik ataçman kaybı (KAK); hastanın yaşamı boyunca periodontitis prognozunu yansıtan, teşhisi ve evrelendirilmesi için kritik bir ölçümdür. 1995-2020 yılları arasındaki 23 çalışmadan 17'si KAS ile osteoporoz arasında anlamlı bir ilişki olduğunu ortaya koymuştur. Her iki hastalıkta yaşa bağlı oksidatif stres ve yaşlanma, proinflamatuvar doku mikroçevresini yönlendiren ve kemik yeniden şekillenme sürecinin bozulmasına neden olan altta yatan mekanizmalardır. D vitamini eksikliği ve sigara kullanımı gibi ortak risk faktörleri bu mekanistik ilişkide önemli rol oynamaktadır. Bu faktörlerin ve aralarındaki etkileşimin anlaşılması, disiplinler arası yönetimi ve her iki hastalığa yönelik potansiyel terapötikleri incelemek için iyi kontrollü uzun dönem çalışmalar yapılmasını gerektirmektedir.
- 22 April 2024
- Published by SDU Journal of Health Sciences in Süleyman Demirel Üniversitesi Sağlık Bilimleri Dergisi
- Vol. 15 (1) , 142-164
Open AccessOsteoporoz ve Periodontal Hastalıklar Arasındaki İlişki Üzerine Derleme
Periodontitis ve osteoporoz, yaşlanan nüfus için önemli halk sağlığı sorunları oluşturan yaygın inflamasyonla ilişkili durumlardır. Periodontal hastalıklar, ağırlıklı olarak dento-gingival dokulardaki disbiyozis ve inflamatuvar nitelikli bir dizi bozukluktan oluşur. Osteoporoz, artan kırık riski ile birlikte kemik mineral yoğunluğu (KMY)’ nun ve yapısının bozulması ile karakterize, yaşa bağlı bir kemik hastalığıdır. Bu derlemede, osteoporoz ve periodontitis arasındaki ilişki hakkında bir güncelleme sağlamak için son 25 yıldaki literatür değerlendirilip, bunların mekanistik bağlantılarının, ortak risk faktörlerinin ve terapötik etkilerinin tartışılması amaçlanmaktadır. Sistemik ve alveolar kemik kaybı (AKK) arasındaki ilişkiyi inceleyen klinik çalışmalarda, 1996-2020 yılları arasındaki 10 araştırma, KMY ile AKK arasında ters bir korelasyon olduğunu ortaya koymuştur. Alveolar kemik kaybının radyografik olarak değerlendirilmesi önemli bir kriter olsa da, klinik ataçman kaybı (KAK); hastanın yaşamı boyunca periodontitis prognozunu yansıtan, teşhisi ve evrelendirilmesi için kritik bir ölçümdür. 1995-2020 yılları arasındaki 23 çalışmadan 17'si KAS ile osteoporoz arasında anlamlı bir ilişki olduğunu ortaya koymuştur. Her iki hastalıkta yaşa bağlı oksidatif stres ve yaşlanma, proinflamatuvar doku mikroçevresini yönlendiren ve kemik yeniden şekillenme sürecinin bozulmasına neden olan altta yatan mekanizmalardır. D vitamini eksikliği ve sigara kullanımı gibi ortak risk faktörleri bu mekanistik ilişkide önemli rol oynamaktadır. Bu faktörlerin ve aralarındaki etkileşimin anlaşılması, disiplinler arası yönetimi ve her iki hastalığa yönelik potansiyel terapötikleri incelemek için iyi kontrollü uzun dönem çalışmalar yapılmasını gerektirmektedir.
- 3 August 2023
- Published by Springer Nature in Clinical Oral Investigations
- Vol. 27 (9) , 5549-5558
Periodontal and cardiovascular therapies modify specialized pro-resolving lipid mediator (sPRLM) (LPXA4, PD1, RvE1, RvD1, and MaR1)-mediated pathway: the first pilot clinical study
Objectives Cardiovascular disease (CVD) and periodontal disease have a common pathogenesis with inflammation and resolution steps. Although the relationships among periodontal disease, CVD, and specialized pro-resolving lipid mediator (sPRLM)s are well known, there is no study about the combined effects of cardiovascular and periodontal treatments on sPRLM levels. It was aimed to evaluate the effects of periodontal and cardiovascular therapies on sPRLMs (lipoxin A4, protectin (PD)1, resolvin (Rv) E1, RvD1, and maresin (MaR)1) in patients with CVD and periodontal disease. Methods This observational study consisted of fifty-five patients with CVD and mild or moderate periodontitis. The clinical periodontal parameters (plaque index, gingival index, probing pocket depth, percentage of bleeding on probing, and clinical attachment level) and blood and unstimulated total saliva samples were obtained at baseline, at 3 months (following only cardiovascular therapy), and at 6 months (following cardiovascular and periodontal therapies). The blood count and serum levels of cardiometabolic biomarkers (white blood cell, neutrophil/lymphocyte, serum total cholesterol (TC), triglyceride, and low and high-density lipoprotein (HDL) levels) were evaluated. sPRLMs were evaluated by ELISA. Results There were significant decreases in body mass index, clinical periodontal parameters, WBC, LDL, PD1, and RvD1 at 6 months compared to baseline. The decreases in TC/HDL, RvE1, and MaR1 levels were significant at 3 and 6 months compared to baseline (p < 0.05). Conclusion(s) The combination of cardiovascular and periodontal treatments leads to significant reductions in clinical periodontal and cardiometabolic parameters and sPRLMs. Clinical relevance Our report, which is the first in their field, suggested that cardiovascular and periodontal therapies provide an important contribution via decreasing the periodontal and atherosclerotic inflammation modulating sPRLMs. This finding will be a big step toward increasing the quality of life in these patients by drawing attention to importance of public health associated with oral hygiene, periodontal health, and systemic phase of periodontal treatment.
- 3 August 2023
- Published by Springer Nature in Clinical Oral Investigations
- Vol. 27 (9) , 5549-5558
Periodontal and cardiovascular therapies modify specialized pro-resolving lipid mediator (sPRLM) (LPXA4, PD1, RvE1, RvD1, and MaR1)-mediated pathway: the first pilot clinical study
Objectives Cardiovascular disease (CVD) and periodontal disease have a common pathogenesis with inflammation and resolution steps. Although the relationships among periodontal disease, CVD, and specialized pro-resolving lipid mediator (sPRLM)s are well known, there is no study about the combined effects of cardiovascular and periodontal treatments on sPRLM levels. It was aimed to evaluate the effects of periodontal and cardiovascular therapies on sPRLMs (lipoxin A4, protectin (PD)1, resolvin (Rv) E1, RvD1, and maresin (MaR)1) in patients with CVD and periodontal disease. Methods This observational study consisted of fifty-five patients with CVD and mild or moderate periodontitis. The clinical periodontal parameters (plaque index, gingival index, probing pocket depth, percentage of bleeding on probing, and clinical attachment level) and blood and unstimulated total saliva samples were obtained at baseline, at 3 months (following only cardiovascular therapy), and at 6 months (following cardiovascular and periodontal therapies). The blood count and serum levels of cardiometabolic biomarkers (white blood cell, neutrophil/lymphocyte, serum total cholesterol (TC), triglyceride, and low and high-density lipoprotein (HDL) levels) were evaluated. sPRLMs were evaluated by ELISA. Results There were significant decreases in body mass index, clinical periodontal parameters, WBC, LDL, PD1, and RvD1 at 6 months compared to baseline. The decreases in TC/HDL, RvE1, and MaR1 levels were significant at 3 and 6 months compared to baseline (p < 0.05). Conclusion(s) The combination of cardiovascular and periodontal treatments leads to significant reductions in clinical periodontal and cardiometabolic parameters and sPRLMs. Clinical relevance Our report, which is the first in their field, suggested that cardiovascular and periodontal therapies provide an important contribution via decreasing the periodontal and atherosclerotic inflammation modulating sPRLMs. This finding will be a big step toward increasing the quality of life in these patients by drawing attention to importance of public health associated with oral hygiene, periodontal health, and systemic phase of periodontal treatment.
- 11 April 2022
- Published by SDU Journal of Health Sciences in Süleyman Demirel Üniversitesi Sağlık Bilimleri Dergisi
- Vol. 13 (1) , 70-79
Periodontal İnflamasyon Salya, Serum C-Reaktif Protein ve Fetuin-A Düzeylerini Etkiler mi?
Amaç: Periodontal hastalık konak savunma sistemini etkileyerek immün yanıtı harekete geçirmektedir. İnflamasyon sonucunda çoğunluğu karaciğer tarafından salgılanan pozitif ve negatif akut faz reaktanları açığa çıkmaktadır. Periodontitisin oluşturduğu inflamatuvar yükü ölçmek için periodontal inflame yüzey alanı (PİYA) son zamanlarda kullanılmaya başlanmıştır. Bu çalışmanın amacı PİYA’nın salya ve serumda pozitif, negatif akut faz reaktanları olan C-reaktif protein (CRP) ve fetuin-A seviyelerine etkilerini incelemektir. Materyal-Metot: Çalışmaya 47 birey dahil edildi ve periodontal durumlarına göre periodontal olarak sağlıklı (n=15), gingivitis (n=15) ve periodontitis (n=17) olmak üzere 3 gruba ayrıldı. Hastaların sosyodemografik verileri anket aracılığıyla kaydedildi, periodontal kayıtları alındı, hastalardan salya ve serum örnekleri toplandı. PİYA, periodontal cep derinliği, klinik ataşman seviyesi ve sondalamada kanama yüzdesi kullanılarak hesaplandı. Salya ve serum örneklerinde CRP ve fetuin-A seviyeleri ELISA ile analiz edildi. Bulgular: Periodontal parametreler ve PİYA periodontitisli grupta sağlıklı ve gingivitisli gruba göre daha yüksekti. Sağlıklı grupla kıyaslandığında periodontitis grubunda salya CRP daha yüksek, salya ve serum fetuin-A ise daha düşüktü. Periodontitis grubunda gingivitisli gruba kıyasla serum fetuin-A daha düşük, salya CRP daha yüksekti. Uyumlandırılmış çok değişkenli lineer regresyon analizi sonucunda PİYA ile salya ve serum fetuin-A’nın negatif, serum CRP’nin ise pozitif ilişkili olduğu belirlendi.Sonuç: Fetuin-A ve CRP seviyelerinin periodontal hastalık patogenezinde biyobelirteç olarak kullanılabileceği öngörülmektedir.
- 11 April 2022
- Published by SDU Journal of Health Sciences in Süleyman Demirel Üniversitesi Sağlık Bilimleri Dergisi
- Vol. 13 (1) , 70-79
Periodontal İnflamasyon Salya, Serum C-Reaktif Protein ve Fetuin-A Düzeylerini Etkiler mi?
Amaç: Periodontal hastalık konak savunma sistemini etkileyerek immün yanıtı harekete geçirmektedir. İnflamasyon sonucunda çoğunluğu karaciğer tarafından salgılanan pozitif ve negatif akut faz reaktanları açığa çıkmaktadır. Periodontitisin oluşturduğu inflamatuvar yükü ölçmek için periodontal inflame yüzey alanı (PİYA) son zamanlarda kullanılmaya başlanmıştır. Bu çalışmanın amacı PİYA’nın salya ve serumda pozitif, negatif akut faz reaktanları olan C-reaktif protein (CRP) ve fetuin-A seviyelerine etkilerini incelemektir. Materyal-Metot: Çalışmaya 47 birey dahil edildi ve periodontal durumlarına göre periodontal olarak sağlıklı (n=15), gingivitis (n=15) ve periodontitis (n=17) olmak üzere 3 gruba ayrıldı. Hastaların sosyodemografik verileri anket aracılığıyla kaydedildi, periodontal kayıtları alındı, hastalardan salya ve serum örnekleri toplandı. PİYA, periodontal cep derinliği, klinik ataşman seviyesi ve sondalamada kanama yüzdesi kullanılarak hesaplandı. Salya ve serum örneklerinde CRP ve fetuin-A seviyeleri ELISA ile analiz edildi. Bulgular: Periodontal parametreler ve PİYA periodontitisli grupta sağlıklı ve gingivitisli gruba göre daha yüksekti. Sağlıklı grupla kıyaslandığında periodontitis grubunda salya CRP daha yüksek, salya ve serum fetuin-A ise daha düşüktü. Periodontitis grubunda gingivitisli gruba kıyasla serum fetuin-A daha düşük, salya CRP daha yüksekti. Uyumlandırılmış çok değişkenli lineer regresyon analizi sonucunda PİYA ile salya ve serum fetuin-A’nın negatif, serum CRP’nin ise pozitif ilişkili olduğu belirlendi.Sonuç: Fetuin-A ve CRP seviyelerinin periodontal hastalık patogenezinde biyobelirteç olarak kullanılabileceği öngörülmektedir.
- 22 December 2021
- Published by Wiley in Journal of Periodontal Research
- Vol. 57 (2) , 371-380
Plasminogen gene polymorphisms [c.924C>T and IVS 8+14 G>A] in periodontitis and familial Mediterranean fever: A case‐control study
Background and objective: The plasminogen (PLG) activation system plays an essential role in severe inflammation based diseases such as periodontitis, destructive membranous periodontal disease (ligneous periodontitis), familial Mediterranean fever (FMF), and amyloidosis. We have aimed to evaluate variations in PLG and the associations between PLG and MEFV genotypes in patients with FMF/ FMF‐related secondary amyloidosis and periodontitis.Material and methods: A total of 247 individuals who were either diagnosed with FMF or systemically healthy were recruited to this human observational study with a cross‐sectional design. All individuals were also diagnosed with periodontitis or periodontally healthy. Blood samples were obtained from patients with FMF and systemically healthy controls. Clinical periodontal indicators were recorded. All polymorphisms located in exons 6 and 8 of PLG and mutations located on exons 2 and 10 of the MEFV gene were analyzed by DNA Sanger Sequencing. Genotypes and allele frequencies of PLG and MEFV were detected and tested by the Hardy‐Weinberg equilibrium. Serum levels of amyloid A (SAA), high‐sensitive C‐reactive protein (hs‐CRP), PLG, and salivary PLG levels were determined by using enzyme‐linked immunosorbent assay (ELISA).Results: Two polymorphisms were identified in PLG: G to A polymorphism on the 14th nucleotide of intron 8 and C to T polymorphism on the 924th nucleotide of the coding region (IVS 8+14 G>A and c.924C>T, respectively). In IVS 8+14 G>A polymorphisms, wild‐type genotype: GG, heterozygote genotype: GA and homozygote genotype: AA. In c.924C>T polymorphism, wild‐type genotype: CC, heterozygote genotype: CT and homozygote genotype: TT. The frequency of the heterozygous polymorphisms of PLG was significantly increased (17.6%) in FMF patients with periodontitis (p = .027). A large proportion of the test group that was heterozygous for MEFV‐R202Q also had heterozygous PLG polymorphisms. Remarkable exacerbation in periodontal parameters was observed in patients with FMF and amyloidosis. SAA and hs‐CRP levels were significantly correlated with salivary PLG levels in patients with periodontitis and heterozygous PLG.Conclusions: The current study describes IVS 8+14 G>A (rs2295368) and c.924C>T (rs1380916375) polymorphisms for the first time in the periodontal literature, which might play an important role in the pathogenesis of periodontitis, FMF, or amyloidosis. The elucidation of PLG polymorphisms is beneficial from a public health perspective by increasing the quality of life in these patients and reducing the mortality and morbidity associated with inflammatory diseases such as periodontal disease, FMF, and FMF‐related amyloidosis.
- 22 December 2021
- Published by Wiley in Journal of Periodontal Research
- Vol. 57 (2) , 371-380
Plasminogen gene polymorphisms [c.924C>T and IVS 8+14 G>A] in periodontitis and familial Mediterranean fever: A case‐control study
Background and objective: The plasminogen (PLG) activation system plays an essential role in severe inflammation based diseases such as periodontitis, destructive membranous periodontal disease (ligneous periodontitis), familial Mediterranean fever (FMF), and amyloidosis. We have aimed to evaluate variations in PLG and the associations between PLG and MEFV genotypes in patients with FMF/ FMF‐related secondary amyloidosis and periodontitis.Material and methods: A total of 247 individuals who were either diagnosed with FMF or systemically healthy were recruited to this human observational study with a cross‐sectional design. All individuals were also diagnosed with periodontitis or periodontally healthy. Blood samples were obtained from patients with FMF and systemically healthy controls. Clinical periodontal indicators were recorded. All polymorphisms located in exons 6 and 8 of PLG and mutations located on exons 2 and 10 of the MEFV gene were analyzed by DNA Sanger Sequencing. Genotypes and allele frequencies of PLG and MEFV were detected and tested by the Hardy‐Weinberg equilibrium. Serum levels of amyloid A (SAA), high‐sensitive C‐reactive protein (hs‐CRP), PLG, and salivary PLG levels were determined by using enzyme‐linked immunosorbent assay (ELISA).Results: Two polymorphisms were identified in PLG: G to A polymorphism on the 14th nucleotide of intron 8 and C to T polymorphism on the 924th nucleotide of the coding region (IVS 8+14 G>A and c.924C>T, respectively). In IVS 8+14 G>A polymorphisms, wild‐type genotype: GG, heterozygote genotype: GA and homozygote genotype: AA. In c.924C>T polymorphism, wild‐type genotype: CC, heterozygote genotype: CT and homozygote genotype: TT. The frequency of the heterozygous polymorphisms of PLG was significantly increased (17.6%) in FMF patients with periodontitis (p = .027). A large proportion of the test group that was heterozygous for MEFV‐R202Q also had heterozygous PLG polymorphisms. Remarkable exacerbation in periodontal parameters was observed in patients with FMF and amyloidosis. SAA and hs‐CRP levels were significantly correlated with salivary PLG levels in patients with periodontitis and heterozygous PLG.Conclusions: The current study describes IVS 8+14 G>A (rs2295368) and c.924C>T (rs1380916375) polymorphisms for the first time in the periodontal literature, which might play an important role in the pathogenesis of periodontitis, FMF, or amyloidosis. The elucidation of PLG polymorphisms is beneficial from a public health perspective by increasing the quality of life in these patients and reducing the mortality and morbidity associated with inflammatory diseases such as periodontal disease, FMF, and FMF‐related amyloidosis.
- 26 May 2021
- Published by Springer Nature in Probiotics and Antimicrobial Proteins
- Vol. 14 (1) , 114-120
Synergistic Effect of Omega-3 and Probiotic Supplementation on Preventing Ligature-Induced Periodontitis
Omega-3 and probiotics were shown to improve periodontal health by modulating the host immune response. Recently, the combination of omega-3 and probiotics has been shown to have a potential synergistic effect on host modulation. The aim of this study was to evaluate the prophylactic role of an omega-3 and probiotic combination on alveolar bone loss (ABL) via inflammatory response in an experimental periodontitis model. Forty-three rats were divided into 5 groups as control (C, n = 8), periodontitis (P, n = 8), omega-3 + periodontitis (O, n = 8), probiotic + periodontitis (Pro, n = 10), and omega-3 + probiotic + periodontitis (OPro, n = 9). Additionally to a standardized diet, omega-3 and/or probiotics were supplemented with oral gavage to the O, Pro, and OPro groups for 44 days. Periodontitis was induced by ligature to the P, O, Pro, and OPro groups on the 30th day for 2 weeks. ABL levels were measured histopathologically, and serum interleukin (IL) 1β, IL6, and IL10 levels were analysed by enzyme-linked immunosorbent assay. ABL increased in all periodontitis groups (P, O, Pro, and OPro), compared to C group. Compared to P group, all oral gavage groups (O, Pro, and OPro) revealed decreased ABL, which was lowest in OPro group. IL1β and IL6 decreased and IL10 increased in OPro group, compared to P group. In conclusion, prophylactic administration of omega-3 and probiotic combination reduced ABL and improved serum IL1β, IL6, and IL10 levels more than their single use.
- 26 May 2021
- Published by Springer Nature in Probiotics and Antimicrobial Proteins
- Vol. 14 (1) , 114-120
Synergistic Effect of Omega-3 and Probiotic Supplementation on Preventing Ligature-Induced Periodontitis
Omega-3 and probiotics were shown to improve periodontal health by modulating the host immune response. Recently, the combination of omega-3 and probiotics has been shown to have a potential synergistic effect on host modulation. The aim of this study was to evaluate the prophylactic role of an omega-3 and probiotic combination on alveolar bone loss (ABL) via inflammatory response in an experimental periodontitis model. Forty-three rats were divided into 5 groups as control (C, n = 8), periodontitis (P, n = 8), omega-3 + periodontitis (O, n = 8), probiotic + periodontitis (Pro, n = 10), and omega-3 + probiotic + periodontitis (OPro, n = 9). Additionally to a standardized diet, omega-3 and/or probiotics were supplemented with oral gavage to the O, Pro, and OPro groups for 44 days. Periodontitis was induced by ligature to the P, O, Pro, and OPro groups on the 30th day for 2 weeks. ABL levels were measured histopathologically, and serum interleukin (IL) 1β, IL6, and IL10 levels were analysed by enzyme-linked immunosorbent assay. ABL increased in all periodontitis groups (P, O, Pro, and OPro), compared to C group. Compared to P group, all oral gavage groups (O, Pro, and OPro) revealed decreased ABL, which was lowest in OPro group. IL1β and IL6 decreased and IL10 increased in OPro group, compared to P group. In conclusion, prophylactic administration of omega-3 and probiotic combination reduced ABL and improved serum IL1β, IL6, and IL10 levels more than their single use.
- 2 March 2021
- Published by Wiley in Journal of Periodontal Research
- Vol. 56 (3) , 606-615
Salivary levels of last generation specific pro‐resolving lipid mediators (SPMs) (protectin and maresin) in patients with cardiovascular and periodontal disease: A case‐control study
Background and Objective Periodontal disease and cardiovascular disease (CVD), which are both deemed to be triggered by inflammation, are recognized as public health problems. Evidence of host modulation via pro‐resolving lipid shown in previous studies supports a two‐way relationship between periodontitis and CVD. Last generation endogenous specific pro‐resolution lipid mediators (SPMs) such as protectins (PDs) and maresins (MaRs) may have potential effects on inflammatory pathogenesis via activation and resolution mechanisms. Currently, there are no data on SPM levels in patients with CVD and periodontal disease. We aimed to evaluate salivary levels of PD and MaR in patients with CVD and periodontal disease. Materials and Methods At total of 181 individuals comprising of 79 healthy controls (C) and 102 patients with diagnosed CVD were included cross‐sectionally. Unstimulated total salivary samples were obtained, and clinical periodontal parameters were determined. Salivary levels of PD and MaR were evaluated by ELISA. The periodontal status of the study population was classified as gingivitis (g) or periodontitis (p). Results Patients with CVD showed lower sociodemographic characteristics, increased clinical periodontal parameters (p < .05), decreased salivary PD (p < .001), and increased salivary MaR levels (p > .05). In the CVDg group, leukocyte, hemoglobin, hematocrit, and high‐density lipoprotein values were higher (p < .05). The CVDp group had a higher neutrophil‐to‐lymphocyte ratio (p < .05). While the PD level was highest in the Cg group, MaR was highest in the CVDp group. The salivary levels of PD and MaR were independent of other confounders in CVD and periodontal disease (p > .05). Conclusion(s) PDs and MaRs may play effective roles in pathogenesis associated with worsening cardiometabolic and periodontal status. These SPMs could also be predictors for conversion from a healthy (systemically and periodontally) to diseased state (CVD and/or periodontitis). Elucidation of the role of SPMs in the relationship between periodontal disease and CVD will enable the development of new host modulation strategies in the prevention and treatment of both diseases, and may also constitute an important public health step by increasing the quality of life of patients with CVD and periodontal disease.
- 2 March 2021
- Published by Wiley in Journal of Periodontal Research
- Vol. 56 (3) , 606-615
Salivary levels of last generation specific pro‐resolving lipid mediators (SPMs) (protectin and maresin) in patients with cardiovascular and periodontal disease: A case‐control study
Background and Objective Periodontal disease and cardiovascular disease (CVD), which are both deemed to be triggered by inflammation, are recognized as public health problems. Evidence of host modulation via pro‐resolving lipid shown in previous studies supports a two‐way relationship between periodontitis and CVD. Last generation endogenous specific pro‐resolution lipid mediators (SPMs) such as protectins (PDs) and maresins (MaRs) may have potential effects on inflammatory pathogenesis via activation and resolution mechanisms. Currently, there are no data on SPM levels in patients with CVD and periodontal disease. We aimed to evaluate salivary levels of PD and MaR in patients with CVD and periodontal disease. Materials and Methods At total of 181 individuals comprising of 79 healthy controls (C) and 102 patients with diagnosed CVD were included cross‐sectionally. Unstimulated total salivary samples were obtained, and clinical periodontal parameters were determined. Salivary levels of PD and MaR were evaluated by ELISA. The periodontal status of the study population was classified as gingivitis (g) or periodontitis (p). Results Patients with CVD showed lower sociodemographic characteristics, increased clinical periodontal parameters (p < .05), decreased salivary PD (p < .001), and increased salivary MaR levels (p > .05). In the CVDg group, leukocyte, hemoglobin, hematocrit, and high‐density lipoprotein values were higher (p < .05). The CVDp group had a higher neutrophil‐to‐lymphocyte ratio (p < .05). While the PD level was highest in the Cg group, MaR was highest in the CVDp group. The salivary levels of PD and MaR were independent of other confounders in CVD and periodontal disease (p > .05). Conclusion(s) PDs and MaRs may play effective roles in pathogenesis associated with worsening cardiometabolic and periodontal status. These SPMs could also be predictors for conversion from a healthy (systemically and periodontally) to diseased state (CVD and/or periodontitis). Elucidation of the role of SPMs in the relationship between periodontal disease and CVD will enable the development of new host modulation strategies in the prevention and treatment of both diseases, and may also constitute an important public health step by increasing the quality of life of patients with CVD and periodontal disease.
- Open Access
- 1 January 2020
- Published by XMLink in Journal of Periodontal & Implant Science
- Vol. 50 (3) , 135-145
Is the relationship between periodontitis and hyperlipidemia mediated by lipoprotein-associated inflammatory mediators?
Fentoğlu Ö, et al. J Periodontal Implant Sci. 2020 Jun;50(3):135-145. https://doi.org/10.5051/jpis.2020.50.3.135
- 1 January 2020
- Published by XMLink in Journal of Periodontal & Implant Science
- Vol. 50 (3) , 135-145
Open AccessIs the relationship between periodontitis and hyperlipidemia mediated by lipoprotein-associated inflammatory mediators?
Fentoğlu Ö, et al. J Periodontal Implant Sci. 2020 Jun;50(3):135-145. https://doi.org/10.5051/jpis.2020.50.3.135
- Open Access
- 1 January 2019
- Published by XMLink in Journal of Periodontal & Implant Science
- Vol. 49 (2) , 105-113
The role of serum lipoxin A4 levels in the association between periodontal disease and metabolic syndrome
Doğan ES, et al. J Periodontal Implant Sci. 2019 Apr;49(2):105-113. https://doi.org/10.5051/jpis.2019.49.2.105
- 1 January 2019
- Published by XMLink in Journal of Periodontal & Implant Science
- Vol. 49 (2) , 105-113
Open AccessThe role of serum lipoxin A4 levels in the association between periodontal disease and metabolic syndrome
Doğan ES, et al. J Periodontal Implant Sci. 2019 Apr;49(2):105-113. https://doi.org/10.5051/jpis.2019.49.2.105
- 13 August 2018
- Published by Wiley in Journal of Periodontology
- Vol. 89 (9) , 1112-1120
The evaluation of salivary oxidative stress in patients with familial Mediterranean fever and chronic periodontitis
Background: Familial Mediterranean fever (FMF) is an inherent autoinflammatory disease and have a high prevalence in Mediterranean countries. The aim of this study was to evaluate salivary levels of oxidative stress parameters in patients with FMF and chronic periodontitis.Methods: The study population consists of 81 patients with FMF and 85 systemically healthy controls. The test and control groups were classified as chronic periodontitis and periodontally healthy [FMF‐periodontitis (n = 37); FMF‐periodontally healthy (n = 44); systemically healthy‐periodontitis (n = 37); systemically and periodontally healthy (n = 48]. Total salivary samples were collected. Clinical periodontal parameters including plaque index, gingival index (GI), probing depth (PD), the percentage of bleeding on probing (BOP%), and clinical attachment level (CAL), were measured. Salivary total antioxidant status (TAS), total oxidant status (TOS), 8‐hydroxydeoxyguanosine (8‐OHdG), malondialdehyde (MDA), and oxidative stress index (OSI) were evaluated.Results: The FMF‐periodontitis group had significantly higher levels of 8‐OHdG, MDA, and OSI than that of the FMF‐periodontally healthy group. In the FMF‐periodontitis group, PD, 8‐OHdG, MDA, and OSI levels were significantly higher than in the systemically healthy‐periodontitis group (P = 0.035, P = 0.000, P = 0.000, and P = 0.000, respectively). 8‐OHdG values were significantly correlated with BOP% and GI, and TOS values were significantly correlated with PD and CAL in the FMF‐periodontitis group.Conclusions: In the presence of FMF and chronic periodontitis, there were increased salivary levels of oxidative stress. Thus, oxidative stress could be an important inflammatory mechanism in the FMF and chronic periodontitis. Further studies need to clarify the oxidative mechanisms of FMF and chronic periodontitis.
- 13 August 2018
- Published by Wiley in Journal of Periodontology
- Vol. 89 (9) , 1112-1120
The evaluation of salivary oxidative stress in patients with familial Mediterranean fever and chronic periodontitis
Background: Familial Mediterranean fever (FMF) is an inherent autoinflammatory disease and have a high prevalence in Mediterranean countries. The aim of this study was to evaluate salivary levels of oxidative stress parameters in patients with FMF and chronic periodontitis.Methods: The study population consists of 81 patients with FMF and 85 systemically healthy controls. The test and control groups were classified as chronic periodontitis and periodontally healthy [FMF‐periodontitis (n = 37); FMF‐periodontally healthy (n = 44); systemically healthy‐periodontitis (n = 37); systemically and periodontally healthy (n = 48]. Total salivary samples were collected. Clinical periodontal parameters including plaque index, gingival index (GI), probing depth (PD), the percentage of bleeding on probing (BOP%), and clinical attachment level (CAL), were measured. Salivary total antioxidant status (TAS), total oxidant status (TOS), 8‐hydroxydeoxyguanosine (8‐OHdG), malondialdehyde (MDA), and oxidative stress index (OSI) were evaluated.Results: The FMF‐periodontitis group had significantly higher levels of 8‐OHdG, MDA, and OSI than that of the FMF‐periodontally healthy group. In the FMF‐periodontitis group, PD, 8‐OHdG, MDA, and OSI levels were significantly higher than in the systemically healthy‐periodontitis group (P = 0.035, P = 0.000, P = 0.000, and P = 0.000, respectively). 8‐OHdG values were significantly correlated with BOP% and GI, and TOS values were significantly correlated with PD and CAL in the FMF‐periodontitis group.Conclusions: In the presence of FMF and chronic periodontitis, there were increased salivary levels of oxidative stress. Thus, oxidative stress could be an important inflammatory mechanism in the FMF and chronic periodontitis. Further studies need to clarify the oxidative mechanisms of FMF and chronic periodontitis.
- 27 February 2018
- Published by Wiley in Journal of Periodontology
- Vol. 89 (4) , 456-465
Serum, salivary, and tissue levels of plasminogen in familial Mediterranean fever, amyloidosis, and chronic periodontitis
Background: There are no published studies regarding the role of the plasminogen (PLG) system in familial Mediterranean fever (FMF), FMF‐associated secondary amyloidosis, or chronic periodontitis (CP), although recent limited data have focused on the association between FMF and chronic periodontitis. Therefore, the aim of this study was to evaluate the serum, salivary, and gingival tissue levels of PLG in patients with CP, FMF, and amyloidosis.Methods: The study population included 122 patients with FMF (only FMF, and FMF and amyloidosis and 128 individuals who were systemically healthy controls. Blood and salivary samples were obtained from the cases and controls, and clinical periodontal parameters were recorded. Serum and salivary PLG levels were assessed. The gingival tissue samples of the case and control groups were analyzed histopathologically and immunohistochemically for amyloid deposition and PLG.Results: The amyloidosis group had significantly more severe clinical periodontal parameters than those of the FMF and systemically healthy groups (P < 0.05). Salivary levels of PLG were significantly higher in the FMF and amyloidosis groups compared with those in the control group (P < 0.001). The FMF with periodontitis and amyloidosis with periodontitis groups had higher salivary PLG levels compared with those in the CP group. Serum and salivary PLG levels were significantly associated with the clinical periodontal parameters in the FMF group. The amyloidosis cases had hyperplasia, severe inflammation, and activation of the gingiva.Conclusion: The PLG system could play an important role in inflammatory diseases, such as chronic periodontitis, FMF, and FMF‐associated secondary amyloidosis.
- 27 February 2018
- Published by Wiley in Journal of Periodontology
- Vol. 89 (4) , 456-465
Serum, salivary, and tissue levels of plasminogen in familial Mediterranean fever, amyloidosis, and chronic periodontitis
Background: There are no published studies regarding the role of the plasminogen (PLG) system in familial Mediterranean fever (FMF), FMF‐associated secondary amyloidosis, or chronic periodontitis (CP), although recent limited data have focused on the association between FMF and chronic periodontitis. Therefore, the aim of this study was to evaluate the serum, salivary, and gingival tissue levels of PLG in patients with CP, FMF, and amyloidosis.Methods: The study population included 122 patients with FMF (only FMF, and FMF and amyloidosis and 128 individuals who were systemically healthy controls. Blood and salivary samples were obtained from the cases and controls, and clinical periodontal parameters were recorded. Serum and salivary PLG levels were assessed. The gingival tissue samples of the case and control groups were analyzed histopathologically and immunohistochemically for amyloid deposition and PLG.Results: The amyloidosis group had significantly more severe clinical periodontal parameters than those of the FMF and systemically healthy groups (P < 0.05). Salivary levels of PLG were significantly higher in the FMF and amyloidosis groups compared with those in the control group (P < 0.001). The FMF with periodontitis and amyloidosis with periodontitis groups had higher salivary PLG levels compared with those in the CP group. Serum and salivary PLG levels were significantly associated with the clinical periodontal parameters in the FMF group. The amyloidosis cases had hyperplasia, severe inflammation, and activation of the gingiva.Conclusion: The PLG system could play an important role in inflammatory diseases, such as chronic periodontitis, FMF, and FMF‐associated secondary amyloidosis.